SANDRA IRVIN: Open Payments
NPI 1477602043 · COLUMBIA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$716 in 35 payments from 15 companies in 2025. Trend: 2023 $494 · 2024 $567 · 2025 $716
Food & beverage: $716
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $177 |
| Novo Nordisk Inc | 5 | $85 |
| ABBVIE INC. | 4 | $67 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Lundbeck LLC | 2 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Amgen Inc. | 2 | $32 |
| Lilly USA, LLC | 2 | $30 |
| Exact Sciences Corporation | 2 | $28 |
Products named: FARXIGA, REXULTI, Auvelity, Wegovy, QULIPTA, CAPLYTA, OTEZLA, BREZTRI.
Industry payments across KY — which companies pay providers there.
